Mannkind reported $23.87M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acceleron Pharma XLRN:US $ 104.83M 13.23M
Adamas Pharmaceuticals ADMS:US 31.53M 405K
Adma Biologics ADMA:US $ 35.12M 1.71M
Biocryst Pharmaceuticals BCRX:US $ 85.58M 6.04M
Biodelivery Sciences International BDSI:US $ 25.47M 4.6M
Chemocentryx CCXI:US $ 39.55M 1M
Dicerna Pharmaceuticals DRNA:US $ 83.23M 1.64M
Dynavax Technologies DVAX:US $ 92.2M 43.38M
Eli Lilly And LLY:US $ 5296.8M 39.9M
Flexion Therapeutics FLXN:US $ 44.98M 73K
Halozyme Therapeutics HALO:US $ 40.24M 3.16M
Immunogen IMGN:US $ 43.44M 873K
Insmed INSM:US $ 150.37M 1.25M
JAZZ PHA JAZZ:US $ 809.75M 11.66M
Karyopharm Therapeutics KPTI:US $ 81.5M 9.85M
Kindred Biosciences KIN:US 12.08M 520K
Macrogenics MGNX:US $ 68.65M 2.39M
Mannkind MNKD:US $ 23.87M 31.81M
Merk MRK:US $ 8328M 1460M
Minerva Neurosciences NERV:US $ 7.52M 1.45M
Novavax NVAX:US $ 485.99M 157.86M
Novo Nordisk A Fs NVO:US 20.37B 2.11B
Peregrine Pharmaceuticals PPHM:US $ 21.96M 1.87M
Pfizer PFE:US $ 16447M 3384M
Xencor XNCR:US $ 61.58M 3.22M